Facing expected season-long shortage, doctors asked to urge patients to carry epinephrine auto-injectors
FRIDAY, July 7, 2017 (HealthDay News) — A shortage of honeybee, wasp, and hornet venom extract has allergists concerned.
Manufacturing problems at one of two companies that produce the extract has reduced the U.S. supply by up to 35 percent, according to CNN. The shortage is expected to continue through the summer — peak sting season, University of Florida Health allergists warn.
The American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma and Immunology recommend reducing maintenance doses of the extracts, increasing time between shots, and delaying treatment for patients at the lowest risk of a bad reaction.
“We have to be diligent and we have to be careful about misuse of these extracts because they’re highly valuable right now,” Mario Rodenas, M.D., a clinical assistant professor of allergy and clinical immunology at the University of Florida College of Medicine in Gainesville, said in a university news release. Physicians should urge their venom-allergic patients to keep epinephrine auto-injectors handy in case of a life-threatening reaction, according to the news release.
More Information
AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report
Exacerbation Risk Profiles Vary With House Dust Mite Sensitization in Pediatric Asthma 
Eosinophilic Esophagitis Prevalence May Be Higher Than Thought in Pediatric Patients With Asthma 
Real-Time Pollen Data Perceived as Valuable Among Some With Seasonal Allergies 
C-Section, Maternal History of Allergic Diseases Linked to Allergic Rhinitis in Offspring 
Glyphosate Exposure During Pregnancy Linked to Preterm Birth 
Family-Based Behavioral Treatment Improves Child Weight Outcomes 
Phelan-McDermid Syndrome More Prevalent Than Previously Estimated 
Consumption of Ultraprocessed Foods in Early Childhood Linked to Brain Development 
